So, Whose Business Is it Anyway?

genomeweb
360dx

So, Whose Business Is it Anyway?

Jan 20, 2011

Ben Goldacre at Bad Science recounts the experience of Ivan Oransky and Adam Marcus at Retraction Watch when they tried to ascertain the circumstances surrounding the retraction of a 2004 Annals of Thoracic Surgery paper.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Multi-Omic Analysis Uncovers Two Subgroups of Rare Olfactory Cancer
GeneWiz, Nashville Biosciences Collaborate to Combine NGS Services, Biobank DNA Samples
Roche, Genialis Partner to Develop Streamlined NGS Workflow for Drug Discovery
Wound Healing Dynamics Traced With Single-Cell Transcriptomics
FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug
Precipio Reports 140 Percent Jump in Preliminary Q3 Revenues

The Scan

In on the Action

NPR reports that with medical data being big business, some companies want to get patients involved.

What's in Store?

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

This Week in PNAS

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Warren Releases Genetic Ancestry Results

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Main menu